Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for AMFPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2026 11.02%
December 31, 2025 7.83%
September 30, 2025 4.61%
June 30, 2025 11.64%
March 31, 2025 10.00%
December 31, 2024 10.87%
September 30, 2024 6.81%
June 30, 2024 14.22%
March 31, 2024 10.99%
December 31, 2023 12.65%
September 30, 2023 8.60%
June 30, 2023 14.91%
March 31, 2023 10.76%
December 31, 2022 15.39%
September 30, 2022 9.51%
June 30, 2022 15.68%
March 31, 2022 10.83%
December 31, 2021 16.68%
September 30, 2021 9.06%
June 30, 2021 16.13%
March 31, 2021 9.64%
December 31, 2020 17.76%
September 30, 2020 10.82%
June 30, 2020 2.88%
March 31, 2020 3.74%
Date Value
December 31, 2019 15.10%
September 30, 2019 7.42%
June 30, 2019 13.87%
March 31, 2019 8.70%
December 31, 2018 15.87%
September 30, 2018 7.06%
June 30, 2018 14.06%
March 31, 2018 8.26%
December 31, 2017 16.17%
September 30, 2017 7.27%
June 30, 2017 13.88%
March 31, 2017 8.96%
December 31, 2016 16.33%
September 30, 2016 8.33%
June 30, 2016 14.05%
March 31, 2016 8.76%
December 31, 2015 14.97%
September 30, 2015 10.14%
June 30, 2015 13.33%
March 31, 2015 7.12%
December 31, 2014 15.95%
September 30, 2014 6.69%
June 30, 2014 12.32%
March 31, 2014 4.12%
December 31, 2013 15.11%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Interpace Biosciences, Inc. 65.37%
Medical Marijuana, Inc. 59.80%
DiaSorin SpA --
Akso Health Group --
Acro Biomedical Co. Ltd. --